Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana.
Yaw Ampem AmoakoAbigail AgbanyoJacob NovignonLucy OwusuJoseph TuffourAdwoa Asante-PokuYohannes HailemichaelIris MosweuRuth CanterCharles OpondoElizabeth AllenCatherine PittDorothy Yeboah-ManuStephen L WalkerMichael MarksRichard Odame Phillipsnull nullPublished in: NIHR open research (2023)
November 2020.